News | Page 6 | Epilepsy Ireland

National Conference Speaker Preview: Dr Colin Doherty

Wednesday, September 19, 2018

Dr. Colin Doherty is a consultant neurologist and Honorary Senior lecturer in neurology at St James's Hospital in Dublin. He was trained in the Partners neurology residency programme at Harvard Medical School, Boston and subsequently completed Fellowships in Epilepsy and Cognition. He has published widely in the areas of brain imaging in epilepsy, the genetics of epilepsy, functional imaging of language and clinical epileptology and neurology.

National Conference Speaker Preview: Mary Fitzsimons

Thursday, September 13, 2018

Mary will discuss the Epilepsy Lighthouse project, which was built upon the success of the Epilepsy Patient Record in Beaumont Hospital. The Project is currently working with 50 children and 50 adults with Intellectual Disabilities who also have epilepsy to develop a new paradigm of healthcare delivery for Ireland.

National Conference Speaker Preview: Jarlath Varley

Monday, September 10, 2018

Jarlath will be discussing "Epilepsy Partnership in Care" or EPiC. The project allows people with epilepsy to work together with health service personnel to design care processes that suit patient needs and respect their individual preferences.The EPiC project is a collaboration between the Health Research Board (HRB), the Health Services Executive and The RCSI.

National Conference Speaker Preview: Emma Eager

Tuesday, September 4, 2018

Helium Arts is the national children's arts and health organisation. The organisation brings art, creativity and play to children and teenagers in hospitals and healthcare settings across Ireland. Emma will be discussing Helium and Epilepsy Ireland joint projects which have helped young people with the condition through creativity.

Buccolam Pharmacy level recall issued by HPRA

Wednesday, August 29, 2018

Important information for those in possession of Buccolam.

The Health Products Regulatory Authority have today (August 29^th) issued a pharmacy-level recall for certain batches of Buccolam Oromucosal Solution.

The reason for the recall is that there is a potential quality defect in the syringe cap components of those batches. Replacement stock is now available for pharmacists to order.

Valproate warning letters sent out

Monday, August 27, 2018

The recently established Valproate Response project team have written to all female patients currently taking valproate (Epilim) outlining the risks of the drug in pregnancy and the need to discuss treatment with their medical team. These letters have been sent to 3,500 patients and are due to arrive in the post today or tomorrow.

Mathematics now part of TFS course

Tuesday, August 21, 2018

Epilepsy Ireland's award-winningTraining for Success course now has mathematics on it's programme. Based on campus at the Institute of Technology Sligo, the course has had over 250 young people with epilepsy attend since its' inception in 1998. Since that year 85% of graduates have found a job or upskilled after they completed the programme.

The FETAC Level 5 Major Award now includes the following modules

Dublin Students take Gold at Global Innovation and Enterprise World Cup

Thursday, August 16, 2018

Three teenagers from St Joseph's College, Lucan, Co. Dublin have won Gold at the SAGE World Cup 2018 taking place in Durban, South Africa. The Global contest recognises Teen Entrepreneurship and Business Literacy.

Senator urges sodium valproate inquiry

Tuesday, August 14, 2018

A senator is calling for an independent inquiry into sodium valproate (Epilim) – an epilepsy drug linked to birth defects. Rose Conway-Walsh, (Sinn Fein), told The Times Ireland Edition that a "do-nothing" approach was not acceptable.

Epilepsy Ireland is now "triple locked"

Thursday, August 9, 2018

Epilepsy Ireland is pleased to announce that we have been awarded the 'Triple Lock Status' by the Charities Institute Ireland (CII) after recently completing full implementation of the Governance Code. Epilepsy Ireland is 'triple locked' as we demonstrated that our charity always upheld the highest standards in transparent reporting, good fundraising and governance.